FluidForm Bio
PrivateLast Round
Seed
Aug 27, 2026
Total Funding Raised
$733,563
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FluidForm Bio is a biotechnology company that develops life-extending tissue therapeutics and 3D bioprinting solutions using its patented FRESH™ technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FluidForm Bio Comparables
Compare FluidForm Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Poietis | 85% | |
| Black Drop Biodrucker GmbH | 82% | |
| Aspect Biosystems | 82% |
FluidForm Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 27, 2026 | ||||
| Convertible Debt | Apr 16, 2025 | ||||
| Strategic | Jan 11, 2022 | ||||
| Grant | May 1, 2021 | ||||
| Grant | Apr 1, 2021 |
Key People
Founding team and executive leadership
FluidForm Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| StartEngine Crowdfunding | Convertible Debt |
| Hackensack Meridian Health | Strategic |
| National Heart, Lung, and Blood Institute | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Raised $2M in a seed funding round.
- Jul 25, 2026
Monthly visitors increased 58% MoM.
FluidForm Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access